Literature DB >> 17588944

The heparin/heparan sulfate sequence that interacts with cyclophilin B contains a 3-O-sulfated N-unsubstituted glucosamine residue.

Christophe Vanpouille1, Audrey Deligny, Maryse Delehedde, Agnès Denys, Aurélie Melchior, Xavier Liénard, Malcolm Lyon, Joël Mazurier, David G Fernig, Fabrice Allain.   

Abstract

Many of the biological functions of heparan sulfate (HS) proteoglycans can be attributed to specialized structures within HS moieties, which are thought to modulate binding and function of various effector proteins. Cyclophilin B (CyPB), which was initially identified as a cyclosporin A-binding protein, triggers migration and integrin-mediated adhesion of peripheral blood T lymphocytes by a mechanism dependent on interaction with cell surface HS. Here we determined the structural features of HS that are responsible for the specific binding of CyPB. In addition to the involvement of 2-O,6-O, and N-sulfate groups, we also demonstrated that binding of CyPB was dependent on the presence of N-unsubstituted glucosamine residues (GlcNH2), which have been reported to be precursors for sulfation by 3-O-sulfotransferases-3 (3-OST-3). Interestingly, 3-OST-3B isoform was found to be the main 3-OST isoenzyme expressed in peripheral blood T lymphocytes and Jurkat T cells. Moreover, down-regulation of the expression of 3-OST-3 by RNA interference potently reduced CyPB binding and consequent activation of p44/42 mitogen-activated protein kinases. Altogether, our results strongly support the hypothesis that 3-O-sulfation of GlcNH2 residues could be a key modification that provides specialized HS structures for CyPB binding to responsive cells. Given that 3-O-sulfation of GlcNH2-containing HS by 3-OST-3 also provides binding sites for glycoprotein gD of herpes simplex virus type I, these findings suggest an intriguing structural linkage between the HS sequences involved in CyPB binding and viral infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17588944     DOI: 10.1074/jbc.M701835200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  Preparation and characterization of heparin hexasaccharide library with N-unsubstituted glucosamine residues.

Authors:  Qun Tao Liang; Jia Yan Du; Qing Fu; Jiang Hui Lin; Zheng Wei
Journal:  Glycoconj J       Date:  2015-08-15       Impact factor: 2.916

2.  Heparan sulfate containing unsubstituted glucosamine residues: biosynthesis and heparanase-inhibitory activity.

Authors:  Satomi Nadanaka; Eko Purunomo; Naoko Takeda; Jun-ichi Tamura; Hiroshi Kitagawa
Journal:  J Biol Chem       Date:  2014-04-21       Impact factor: 5.157

3.  Preparation of heparin/heparan sulfate oligosaccharides with internal N-unsubstituted glucosamine residues for functional studies.

Authors:  Zheng Wei; Jon Andrew Deakin; Bärbel Sabine Blaum; Dušan Uhrín; John Thomas Gallagher; Malcolm Lyon
Journal:  Glycoconj J       Date:  2011-09-21       Impact factor: 2.916

4.  Heparan sulfate modification of the transmembrane receptor CD47 is necessary for inhibition of T cell receptor signaling by thrombospondin-1.

Authors:  Sukhbir Kaur; Svetlana A Kuznetsova; Michael L Pendrak; John M Sipes; Martin J Romeo; Zhuqing Li; Lijuan Zhang; David D Roberts
Journal:  J Biol Chem       Date:  2011-02-22       Impact factor: 5.157

5.  Synthesis of heparan sulfate with cyclophilin B-binding properties is determined by cell type-specific expression of sulfotransferases.

Authors:  Audrey Deligny; Agnès Denys; Adeline Marcant; Aurélie Melchior; Joël Mazurier; Toin H van Kuppevelt; Fabrice Allain
Journal:  J Biol Chem       Date:  2009-11-23       Impact factor: 5.157

Review 6.  Heparan sulfate 3-O-sulfation: a rare modification in search of a function.

Authors:  Bryan E Thacker; Ding Xu; Roger Lawrence; Jeffrey D Esko
Journal:  Matrix Biol       Date:  2013-12-19       Impact factor: 11.583

Review 7.  Heparan sulfate biosynthesis: regulation and variability.

Authors:  Johan Kreuger; Lena Kjellén
Journal:  J Histochem Cytochem       Date:  2012-10-04       Impact factor: 2.479

Review 8.  Viral entry mechanisms: human papillomavirus and a long journey from extracellular matrix to the nucleus.

Authors:  Martin Sapp; Malgorzata Bienkowska-Haba
Journal:  FEBS J       Date:  2009-12       Impact factor: 5.542

Review 9.  Therapeutically targeting protein-glycan interactions.

Authors:  A Rek; E Krenn; A J Kungl
Journal:  Br J Pharmacol       Date:  2009-04-09       Impact factor: 8.739

10.  Target cell cyclophilins facilitate human papillomavirus type 16 infection.

Authors:  Malgorzata Bienkowska-Haba; Hetalkumar D Patel; Martin Sapp
Journal:  PLoS Pathog       Date:  2009-07-24       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.